| WHO benchmarks for International Health Regulations (IHR) capacities World Health Organization World Health Organization, 2019 | 3258* | 2019 |
| Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production A Merovci, C Solis-Herrera, G Daniele, R Eldor, TV Fiorentino, D Tripathy, ... The Journal of clinical investigation 124 (2), 509-514, 2014 | 874 | 2014 |
| Assessment of pancreatic β-cell function: review of methods and clinical applications E Cersosimo, C Solis-Herrera, M E Trautmann, J Malloy, C L Triplitt Current diabetes reviews 10 (1), 2-42, 2014 | 293 | 2014 |
| Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 Diabetes AGM Daniele G, Xiong J, Solis-Herrera C, Merovci A, Eldor R, Tripathy D ... Diabetes Care, 2016 | 210 | 2016 |
| Dapagliflozin lowers plasma glucose concentration and improves β-cell function DFRA Merovci A, Mari A, Solis C, Xiong J, Daniele G, Chavez-Velazquez A ... J Clin Endocrinol Metab 100 (5), 1927-32, 2015 | 206 | 2015 |
| Pathogenesis of type 2 diabetes mellitus E Cersosimo, C Triplitt, C Solis-Herrera, LJ Mandarino, RA DeFronzo Endotext, 12-16, 2000 | 160 | 2000 |
| Classification of diabetes mellitus C Solis-Herrera, C Triplitt, C Reasner, RA DeFronzo, E Cersosimo | 104 | 2015 |
| Empagliflozin Treatment Is Associated With Improved β-Cell Function in Type 2 Diabetes Mellitus H Al Jobori, G Daniele, J Adams, E Cersosimo, C Solis-Herrera, C Triplitt, ... The Journal of Clinical Endocrinology & Metabolism 103 (4), 1402-1407, 2018 | 89 | 2018 |
| Mechanisms of glucose lowering of dipeptidyl peptidase-4 inhibitor sitagliptin when used alone or with metformin in type 2 diabetes: a double-tracer study C Solis-Herrera, C Triplitt, JJ Garduno-Garcia, J Adams, RA DeFronzo, ... Diabetes care 36 (9), 2756-2762, 2013 | 79 | 2013 |
| Pathogenesis of type 2 diabetes mellitus C Solis-Herrera, C Triplitt, E Cersosimo, RA DeFronzo Endotext [Internet], 2021 | 64 | 2021 |
| Pioglitazone improves left ventricular diastolic function in subjects with diabetes GD Clarke, C Solis-Herrera, M Molina-Wilkins, S Martinez, A Merovci, ... Diabetes care 40 (11), 1530-1536, 2017 | 62 | 2017 |
| Therapeutic Manipulation of Myocardial Metabolism: JACC State-of-the-Art Review H Honka, C Solis-Herrera, C Triplitt, L Norton, J Butler, RA DeFronzo Journal of the American College of Cardiology 77 (16), 2022-2039, 2021 | 55 | 2021 |
| Effect of dapagliflozin with and without acipimox on insulin sensitivity and insulin secretion in T2DM males A Merovci, M Abdul-Ghani, A Mari, C Solis-Herrera, J Xiong, G Daniele, ... The Journal of Clinical Endocrinology & Metabolism 101 (3), 1249-1256, 2016 | 44 | 2016 |
| Empagliflozin and linagliptin combination therapy for treatment of patients with type 2 diabetes mellitus C Triplitt, C Solis-Herrera, E Cersosimo, M Abdul-Ghani, RA Defronzo Expert opinion on pharmacotherapy 16 (18), 2819-2833, 2015 | 39 | 2015 |
| Nephropathy in youth and young adults with type 2 diabetes C Solis-Herrera, CL Triplitt, JL Lynch Current diabetes reports 14, 1-9, 2014 | 31 | 2014 |
| Inhibition of renal glucose reabsorption as a novel treatment for diabetes patients E Cersosimo, C Solis-Herrera, C Triplitt Jornal Brasileiro de Nefrologia 36 (1), 80-92, 2014 | 26 | 2014 |
| Increase in endogenous glucose production with SGLT2 inhibition is attenuated in individuals who underwent kidney transplantation and bilateral native nephrectomy G Daniele, C Solis-Herrera, A Dardano, A Mari, A Tura, L Giusti, ... Diabetologia 63, 2423-2433, 2020 | 24 | 2020 |
| Effect of mild physiologic hyperglycemia on insulin secretion, insulin clearance, and insulin sensitivity in healthy glucose-tolerant subjects A Merovci, D Tripathy, X Chen, I Valdez, M Abdul-Ghani, C Solis-Herrera, ... Diabetes 70 (1), 204-213, 2021 | 23 | 2021 |
| GLP-1 receptor agonists: practical considerations for clinical practice C Triplitt, C Solis-Herrera The Diabetes Educator 41 (1_suppl), 32S-46S, 2015 | 23 | 2015 |
| Management of type 2 diabetes with oral semaglutide: Practical guidance for pharmacists MP Kane, CL Triplitt, CD Solis-Herrera American Journal of Health-System Pharmacy 78 (7), 556-567, 2021 | 22 | 2021 |
